These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 22528931)

  • 1. Evaluation of breast cancer using proton MR spectroscopy: total choline peak integral and signal-to-noise ratio as prognostic indicators.
    Shin HJ; Baek HM; Cha JH; Kim HH
    AJR Am J Roentgenol; 2012 May; 198(5):W488-97. PubMed ID: 22528931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1H MR spectroscopy of invasive ductal carcinoma: correlations with FDG PET and histologic prognostic factors.
    Tozaki M; Hoshi K
    AJR Am J Roentgenol; 2010 May; 194(5):1384-90. PubMed ID: 20410429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo proton MR spectroscopy of the breast using the total choline peak integral as a marker of malignancy.
    Sardanelli F; Fausto A; Di Leo G; de Nijs R; Vorbuchner M; Podo F
    AJR Am J Roentgenol; 2009 Jun; 192(6):1608-17. PubMed ID: 19457825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of pathologic response to neoadjuvant chemotherapy in patients with breast cancer using diffusion-weighted imaging and MRS.
    Shin HJ; Baek HM; Ahn JH; Baek S; Kim H; Cha JH; Kim HH
    NMR Biomed; 2012 Dec; 25(12):1349-59. PubMed ID: 22566277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton MR spectroscopy with choline peak as malignancy marker improves positive predictive value for breast cancer diagnosis: preliminary study.
    Bartella L; Morris EA; Dershaw DD; Liberman L; Thakur SB; Moskowitz C; Guido J; Huang W
    Radiology; 2006 Jun; 239(3):686-92. PubMed ID: 16603660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinally monitoring chemotherapy effect of malignant musculoskeletal tumors with in vivo proton magnetic resonance spectroscopy: an initial experience.
    Hsieh TJ; Li CW; Chuang HY; Liu GC; Wang CK
    J Comput Assist Tomogr; 2008; 32(6):987-94. PubMed ID: 19204465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
    Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
    Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of perfusion parameters on dynamic contrast-enhanced MRI with prognostic factors and subtypes of breast cancers.
    Koo HR; Cho N; Song IC; Kim H; Chang JM; Yi A; Yun BL; Moon WK
    J Magn Reson Imaging; 2012 Jul; 36(1):145-51. PubMed ID: 22392859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of choline and pharmacokinetic parameters in breast cancer measured by MR spectroscopic imaging and dynamic contrast enhanced MRI.
    Su MY; Baik HM; Yu HJ; Chen JH; Mehta RS; Nalcioglu O
    Technol Cancer Res Treat; 2006 Aug; 5(4):401-10. PubMed ID: 16866570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast Magnetic Resonance Spectroscopy at 3 T in Biopsy-Proven Breast Cancers: Does Choline Peak Correlate With Prognostic Factors?
    Galati F; Luciani ML; Caramanico C; Moffa G; Catalano C; Pediconi F
    Invest Radiol; 2019 Dec; 54(12):767-773. PubMed ID: 31356383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can the signal-to-noise ratio of choline in magnetic resonance spectroscopy reflect the aggressiveness of endometrial cancer?
    Han X; Kang J; Zhang J; Xiu J; Huang Z; Yang C; Sun X; Fu C; Liu Q
    Acad Radiol; 2015 Apr; 22(4):453-9. PubMed ID: 25641318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined DCE-MRI and single-voxel 2D MRS for differentiation between benign and malignant breast lesions.
    Lipnick S; Liu X; Sayre J; Bassett LW; Debruhl N; Thomas MA
    NMR Biomed; 2010 Oct; 23(8):922-30. PubMed ID: 20878970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved diagnostic accuracy in differentiating malignant and benign lesions using single-voxel proton MRS of the breast at 3 T MRI.
    Suppiah S; Rahmat K; Mohd-Shah MN; Azlan CA; Tan LK; Aziz YF; Vijayananthan A; Wui AL; Yip CH
    Clin Radiol; 2013 Sep; 68(9):e502-10. PubMed ID: 23706826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological parameters and biological markers predicting non-sentinel node metastasis in sentinel node-positive breast cancer patients.
    Kwon Y; Ro J; Kang HS; Kim SK; Hong EK; Khang SK; Gong G; Ro JY
    Oncol Rep; 2011 Apr; 25(4):1063-71. PubMed ID: 21258771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 status with total choline concentration and tumor volume in breast cancer patients: an MRI and in vivo proton MRS study.
    Sah RG; Sharma U; Parshad R; Seenu V; Mathur SR; Jagannathan NR
    Magn Reson Med; 2012 Oct; 68(4):1039-47. PubMed ID: 22213087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast density, scintimammographic (99m)Tc(V)DMSA uptake, and calcitonin gene related peptide (CGRP) expression in mixed invasive ductal associated with extensive in situ ductal carcinoma (IDC + DCIS) and pure invasive ductal carcinoma (IDC): correlation with estrogen receptor (ER) status, proliferation index Ki-67, and histological grade.
    Papantoniou V; Sotiropoulou E; Valsamaki P; Tsaroucha A; Sotiropoulou M; Ptohis N; Stipsanelli A; Dimitrakakis K; Marinopoulos S; Tsiouris S; Antsaklis A
    Breast Cancer; 2011 Oct; 18(4):286-91. PubMed ID: 20143189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrast/Noise ratio on conventional MRI and choline/creatine ratio on proton MRI spectroscopy accurately discriminate low-grade from high-grade cerebral gliomas.
    Fayed N; Morales H; Modrego PJ; Pina MA
    Acad Radiol; 2006 Jun; 13(6):728-37. PubMed ID: 16679275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary study of 3T 1H MR spectroscopy in bone and soft tissue tumors.
    Qi ZH; Li CF; Li ZF; Zhang K; Wang Q; Yu DX
    Chin Med J (Engl); 2009 Jan; 122(1):39-43. PubMed ID: 19187615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of her-2/neu gene amplification with other prognostic and predictive factors in female breast carcinoma.
    Ariga R; Zarif A; Korasick J; Reddy V; Siziopikou K; Gattuso P
    Breast J; 2005; 11(4):278-80. PubMed ID: 15982396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of Bcl-2 in invasive mammary carcinomas: a comparative clinicopathologic study between "triple-negative" and non-"triple-negative" tumors.
    Tawfik K; Kimler BF; Davis MK; Fan F; Tawfik O
    Hum Pathol; 2012 Jan; 43(1):23-30. PubMed ID: 21777944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.